Carillo, Gabriel C.

HRN: 21-87-75  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/04/2022
09/10/2022
IV
2.25g
Q6H
T/C Sepsis; Covid Pneumonia Severe
Waiting Final Action 
09/05/2022
REMDESIVIR 100MG (VIAL)
09/05/2022
09/09/2022
IV
200mg LD Then 100mg
Once A Day
COVID-19 Infection RAgT Confirmed-severe
Waiting Final Action 
09/12/2022
CLINDAMYCIN 300MG (CAP)
09/12/2022
09/21/2022
ORAL
300mg
Qid
CAP MR Covid 19 Pneumonia Severe
Waiting Final Action 
09/12/2022
CLOXACILLIN 500MG (CAP)
09/12/2022
09/21/2022
ORAL
500mg
Qid
CAP MR Covid 19 Pneumonia Severe
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: